Nicole Devoid, in Hinesburg, VT - Occupational Therapist

Nicole Devoid, is a Occupational Therapist based in Hinesburg, Vermont. Nicole Devoid is licensed to practice in Vermont (license number 072.0109187) and her current practice location is 587 Texas Hill Rd, Hinesburg, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 578-4748.

NPI number for Nicole Devoid is 1780032300 and her current mailing address is 587 Texas Hill Rd, Hinesburg, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1780032300.

Contact Information

	Nicole Devoid,
	587 Texas Hill Rd, Hinesburg, VT 05461-9564
	(802) 578-4748
	Not Available

Healthcare Provider's Profile

Full Name	Nicole Devoid
Gender	Female
Speciality	Occupational Therapist
Location	587 Texas Hill Rd, Hinesburg, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1780032300
Provider Enumeration Date: 05/25/2016
Last Update Date: 05/25/2016

Medical Identifiers

Medical identifiers for Nicole Devoid such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1780032300	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	072.0109187 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicole Devoid is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nicole Devoid, 587 Texas Hill Rd, Hinesburg, VT 05461-9564 Ph: () -	Nicole Devoid, 587 Texas Hill Rd, Hinesburg, VT 05461-9564 Ph: (802) 578-4748

News Archive

Firearm injury survivors more likely to be readmitted to hospital for further treatment

Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.

Remnant fetal tissue could contribute to enlarged prostate in later life

New research from Michigan State University indicates that embryonic tissue, key to the development of a baby's gender, could contribute to an enlarged prostate, or BPH, in men later in life.

Maternal stress, depression during pregnancy may activate protective mechanisms in infants

Maternal stress and depression during pregnancy may activate certain protective mechanisms in babies. Psychologists from the University of Basel together with international colleagues report that certain epigenetic adaptations in newborns suggest this conclusion.

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

GE Healthcare to supply technetium-99m generators following FDA approval

Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.

Nicole Devoid, - Occupational Therapist in Hinesburg, VT